Cytek Biosciences, Inc. (CTKB) Financials
CTKB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 519.4 million | 103.9 million |
2023-06-30 | 525.1 million | 100.9 million |
2023-03-31 | 524.6 million | 101.1 million |
2022-12-31 | 519.5 million | 93.9 million |
CTKB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.6 million | 5.8 million |
2023-06-30 | -4.2 million | 5.9 million |
2023-03-31 | 2.4 million | 4.7 million |
2022-12-31 | -417000 | 4.5 million |
CTKB Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-09-30 | -6.5 million |
2023-06-30 | -4.4 million |
2023-03-31 | -6.8 million |
2022-12-31 | 3.7 million |
CTKB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 288.0 million | - | 10.1 million |
2023-06-30 | 298.8 million | 1.9 million | 13.8 million |
2023-03-31 | 299.0 million | 2.1 million | 11.5 million |
2022-12-31 | 341.1 million | 2.3 million | 12.3 million |
CTKB Shares Outstanding
CTKB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 1.4 million | 11.2 million | 10.4 million | 12.1 million |
2023-06-30 | 1.4 million | 12.1 million | 10.8 million | 14.4 million |
2023-03-31 | 505000 | 10.0 million | 12.1 million | 11.1 million |
2022-12-31 | 6.6 million | 9.7 million | 10.5 million | 9.0 million |
CTKB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 48.0 million | 20.8 million |
2023-06-30 | 49.7 million | 21.5 million |
2023-03-31 | 37.1 million | 16.1 million |
2022-12-31 | 48.3 million | 19.0 million |
CTKB
Price: $6.22
52 week price:
Earnings Per Share: -0.09 USD
P/E Ratio: -76.75
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 1.0 million
Market Capitalization: 855.6 million